ITIL-306 in Advanced Solid Tumors

ITIL-306 in Advanced Solid Tumors
Conditions:   Epithelial Ovarian Cancer;   Non-small Cell Lung Cancer;   Renal Cell Carcinoma
Intervention:   Biological: ITIL-306
Sponsor:   Instil Bio

Source: View full study details on

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

July 12, 2022Comments | Endocrinology Clinical Trials | Endocrinology Studies | US National Library of Medicine